GW Henssler & Associates’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,481
Closed -$206K 191
2025
Q1
$206K Buy
+8,481
New +$206K 0.01% 167